Drugs & Targets European Commission adopted positive opinion of rucaparib in platinum-based chemotherapy December 14, 2018Vol.44 No.46
Drugs & Targets FDA grants orphan drug designation to Merck’s M7824 in biliary tract cancer December 14, 2018Vol.44 No.46
Clinical Roundup Kadcyla cut risk of disease recurrence vs. Herceptin in HER2-positive early breast cancer with residual disease after neoadjuvant treatment December 14, 2018Vol.44 No.46
Clinical Roundup BYL719 + fulvestrant improved PFS in PIK3CA mutated HR+/HER2- advanced breast cancer December 14, 2018Vol.44 No.46
Clinical Roundup Data show efficacy, tolerability of Kisqali combination in HR+/HER2- advanced breast cancer with visceral disease December 14, 2018Vol.44 No.46
Clinical Roundup Insight Genetics launches test for triple negative breast cancer December 14, 2018Vol.44 No.46
Clinical Roundup Biotheranostics presents data on the Breast Cancer Index December 14, 2018Vol.44 No.46
Clinical Roundup First-line immunotherapy combination fails to improve OS in lung cancer December 14, 2018Vol.44 No.46
